ICON Issues Financial Guidance for Full Year 2025. Contacts. Investor Relations +1 888 381 7923 Nigel Clerkin Chief Financial Officer + 353 1 291 2000 ...

New guidance from the World Health Organization (WHO) sets essential standards to inform future research and development on genetically modified mosquitoes, particularly in addressing issues ...

The most recent guidance for Icon (ICLR) was reported on April 30, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $12.75 to $14.25, compared to the ...

ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research organization said that it expects to report 2025 revenue of $8.05B to $8.650B ...

New Zealand's biggest electricity and gas distributor Vector Ltd. <VCT.NZ> reaffirmed its guidance for the full year to June 2010 on Tuesday.

The guidance document is a culmination of more than three years of work and will be a valuable new tool to support global efforts to prevent and control vector-borne diseases (VBDs).

ICON plc (ICLR) stock traded lower ... The company trimmed its full-year adjusted earnings per share guidance by $1.10 on both ends to $13.90-$14.10 and cut its revenue guidance by $190M-$250M to ...

ICON Public Limited Company’s (NASDAQ:ICLR) third quarter revenue was $2.03 billion, represents a year-on-year decrease of 1.2% or 1% on a constant currency basis.

Full year 2025 financial guidance excludes any potential share repurchase or additional M&A activity. CEO Dr. Steve Cutler commented, "ICON continues to navigate dynamic clinical development ...

ICON plc,, a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2023. For the full year 2023 ...

ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025.

ICON Issues Financial Guidance for Full Year 2024 Highlights Full Year 2024 Revenue guidance in the range of $8,400 - $8,800 million, representing growth of 3.2% – 8.1% over Full Year 2023 ...